C-Path's K. Romero Co-Authors Special Report- Striving for an Integrated Drug-Development Process for Neurodegeneration: the Coalition Against Major Diseases
October 2, 2011
Alzheimer’s and Parkinson’s diseases are the two main neurodegenerative disorders and despite the public health need, drug development for these conditions has been plagued by a high attrition rate in the late phases of evaluation.
